Indeed, data from the Kaplan–Meier plotter (kmplot.com (accessed on 21 December 2023)) and from the literature indicate that high expression of TLR2 is associated with poor relapse-free survival in breast cancer patients [8]. Here, TLR2 is linked to breast carcinoma.